Skip to content

Assessing brain hemodynamics using Arterial Spin Labeling.

Assessing brain hemodynamics using Arterial Spin Labeling. - A-CO2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37548
Enrollment
180
Registered
2012-06-06
Start date
2012-07-12
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular disease stroke

Interventions

All subjects will be exposed to a CO2- challenge during an ASL MRI research in which the CVR and OEF will be measured. During this research 6 blocks of increased CO2-concentration will be administe

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the healthy volunteers: - 18 years or older - male or female - informed consent after extensive explanation about the device and the research protocol - healthy;Inclusion criteria for patients: - 18 years or older - male or female - (A)symptomatic extracranial vascular disease (stenosis of 70-100%) or Symptomatic middle cerebral artery occlusion - Informed consent after extensive explanation about the device and the research protocol - healthy

Exclusion criteria

Exclusion criteria: Exclusion criteria for the healthy volunteers: - Contraindications for MRI (claustrophobia, or standard MRI contraindications such as pacemakers or specific metal objects in or around the body) - Previous history of ischemic symptoms - Minors or (legally) incompetent adults;Exclusion criteria for patients: - Contraindications for MRI (claustrophobia, or standard MRI contraindications such as pacemakers or specific metal objects in or around the body) - Unwilling or unable to co-operate with breathing manoeuvres - Known cardiac or pulmonary disease - altered consciousness - Non compliance with prescribed anti-seizure medication - Minors or (legally) incompetent adults

Design outcomes

Primary

MeasureTime frame
The main endpoint in part 1 is to test the feasibility and safety of the CO2-challenge in healthy volunteers. During this part we will also optimize the sequences and the scan protocol. In part 2 of this research the CVR and the OEF in the different patient populations will be compared with the CVR and OEF in the control group.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)